BACKGROUND Obesity and atrial fibrillation (AF) frequently coexist. Weight loss reduces the burden of AF, but whether this is sustained, has a dose effect, or is influenced by weight fluctuation is unknown.
R ecent epidemiological data confirmed the emergence of obesity and atrial fibrillation (AF) as global epidemics (1, 2) . In the United States, the prevalence of obese individuals has risen 3-fold since 1960, with 1 in every 3 persons being obese (3) . If such trends continue unabated, it is estimated that 164 million Americans will be obese by 2030, with an additional health care cost of $66 billion annually (4, 5) . The prevalence of AF is projected to reach 15.9 million in the United States by 2050 (2, 6, 7) . Because obesity is independently associated with AF, these dual epidemics confer an enormous management and economic burden (8) (9) (10) (11) .
Obesity and its associated cardiometabolic comorbidities, such as hypertension, diabetes mellitus, and sleep apnea have been proposed as contributors to the expanding epidemic of AF (8, 12, 13) , and are thus potential targets for intervention to stem the expanding AF epidemic. Weight loss in the short term results in a reduction in the symptomatic AF burden (14) . Recent data demonstrated that aggressive weight and risk factor management improves maintenance of sinus rhythm after AF ablation (15) .
Whether a critical weight loss threshold is required, or if benefits conferred by the initial weight loss are sustained in the long term is unknown. Furthermore, obese individuals frequently oscillate in weight over time, and the impact of such weight fluctuation on the arrhythmia burden is not known.
We hypothesized that weight loss, if sustained, will be of incremental benefit in rhythm control. In this study, we assess the long-term impact of weight loss and weight fluctuation on rhythm control in obese individuals with AF. STUDY PROTOCOL AND DESIGN. All patients were counseled on the importance of weight and risk factor management, with optional participation in a dedicated physician-led weight management clinic or self-managed weight loss program.
W e i g h t m a n a g e m e n t . The weight and other risk factor management protocols have been presented previously and are outlined in the Online Appendix (15) . In brief, a structured motivational and goaldirected program using face-to-face counseling was used for weight reduction. Patients were reviewed regularly (every 3 months in the initial phase), and encouraged to use support counseling and schedule more frequent reviews as required. Initial weight reduction was attempted by a meal plan and behavior modification. Participants were required to maintain a diet and physical activity diary. Association/American College of Cardiology guidelines recognize that any weight loss $3% is considered a meaningful reduction (16) . To determine the dose-response effect of weight loss on AF burden, groups were divided as follows: $10% weight loss (group 1), 3% to 9% weight loss (group 2), and <3% weight loss or weight gain (group 3). OUTCOMES. The primary outcome was AF burden as determined by symptom burden and AF freedom. AF symptom burden was determined by the AF Severity Scale (AFSS) (University of Toronto, Toronto, Ontario, Canada), which quantitates 3 domains of AF-related symptoms: frequency, duration, and severity (18) .
The AFSS has been clinically validated and used for assessment of AF burden (14, 15) . In addition, it pro- Table 2 shows the impact of weight management on various cardiac risk factors. L i p i d m a n a g e m e n t . A greater reduction in lowdensity cholesterol, triglycerides, and total cholesterol levels was seen in group 1 compared with groups EFFECT OF WEIGHT LOSS ON ATRIAL FIBRILLATION SYMPTOM BURDEN. AF frequency, duration, symptoms, and symptom severity were improved in groups 1 and 2 compared with group 3 (p < 0.001) ( Table 2 ).
The global well-being score improved by 5.9 AE 0.9 in group 1 and was higher than in groups 2 and 3 (p < 0.001). 69% of the <2% group, 55% of the 2% to 5% group, and 30% of the >5% weight fluctuation group (p < 0.001). It is probable that multiple mechanisms contributed to the impact of weight loss on reduction of AF burden. Obesity clusters with other cardiovascular risk factors, including impaired glucose tolerance, dyslipidemia, hypertension, and sleep apnea (26, 27) , which are all associated with an increased AF risk in the general population (12, 13, 28) . Intentional weight loss in obese patients systematically reduces these allied risk factors (29) (30) (31) (32) (33) . In this study, we observed the beneficial effects of weight loss on BP, diabetic control, the lipid profile, and inflammation, all of Weight Management and AF which might have contributed to reduction of the AF burden. Our previous work demonstrated that shortterm weight loss and other risk factor management resulted in a reduction of the AF burden (14, 15) . The present study demonstrated that these beneficial effects on AF burden persisted during long-term follow up, were dose-dependent, but were also partially offset in the face of significant weight fluctuation.
STUDY LIMITATIONS. This study has the potential for bias inherent to observational studies. However, measurement bias was reduced through standardized processes in our clinic, and the evaluation by operators was blinded to the patient's weight management regimen. AF burden assessment using 7-day Holter monitoring might miss some AF episodes. However, this was utilized for AF freedom assessment in both the groups and was a limitation for all groups. 
